Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Net Income: 2009-2024

Historic Net Income for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to -$15.3 million.

  • OptimizeRx's Net Income rose 10853.79% to $779000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 11520.25%. This contributed to the annual value of -$15.3 million for FY2024, which is 1282.02% up from last year.
  • Per OptimizeRx's latest filing, its Net Income stood at -$15.3 million for FY2024, which was up 1282.02% from -$17.6 million recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Net Income peaked at $378079.0 during FY2021, and registered a low of -$17.6 million during FY2023.
  • In the last 5 years, OptimizeRx's Net Income had a median value of -$11.4 million in 2022 and averaged -$9.2 million.
  • Per our database at Business Quant, OptimizeRx's Net Income soared by 11712.99% in 2021 and then tumbled by 312541.0% in 2022.
  • Over the past 5 years, OptimizeRx's Net Income (Annual) stood at -$2.2 million in 2020, then surged by 117.13% to $378079.0 in 2021, then plummeted by 3125.41% to -$11.4 million in 2022, then plummeted by 53.57% to -$17.6 million in 2023, then rose by 12.82% to -$15.3 million in 2024.
  • Its Net Income stands at -$15.3 million for FY2024, versus -$17.6 million for FY2023 and -$11.4 million for FY2022.